Bank of America’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-368
| Closed | -$304 | – | 8550 |
|
|
2025
Q1 | $304 | Sell |
368
-2,854
| -89% | -$2.75K | ﹤0.01% | 7610 |
|
|
2024
Q4 | $3.06K | Sell |
3,222
-311
| -9% | -$293 | ﹤0.01% | 7150 |
|
|
2024
Q3 | $3.53K | Sell |
3,533
-2,590
| -42% | -$2.87K | ﹤0.01% | 7067 |
|
|
2024
Q2 | $7.59K | Buy |
6,123
+379
| +7% | +$386 | ﹤0.01% | 6940 |
|
|
2024
Q1 | $7.47K | Sell |
5,744
-29
| -0.5% | -$33 | ﹤0.01% | 6936 |
|
|
2023
Q4 | $7.22K | Buy |
5,773
+29
| +0.5% | +$32 | ﹤0.01% | 6950 |
|
|
2023
Q3 | $7.47K | Hold |
5,744
| – | – | ﹤0.01% | 6922 |
|
|
2023
Q2 | $9.88K | Sell |
5,744
-40,405
| -88% | -$64.2K | ﹤0.01% | 6866 |
|
|
2023
Q1 | $67.4K | Buy |
46,149
+7,775
| +20% | +$14.9K | ﹤0.01% | 6399 |
|
|
2022
Q4 | $62.2K | Buy |
38,374
+19,473
| +103% | +$44.8K | ﹤0.01% | 6410 |
|
|
2022
Q3 | $63K | Buy |
18,901
+2,685
| +17% | +$12.1K | ﹤0.01% | 6565 |
|
|
2022
Q2 | $59K | Sell |
16,216
-141,668
| -90% | -$642K | ﹤0.01% | 6754 |
|
|
2022
Q1 | $1.14M | Buy |
157,884
+132,246
| +516% | +$1.13M | ﹤0.01% | 5109 |
|
|
2021
Q4 | $349K | Buy |
25,638
+12,794
| +100% | +$200K | ﹤0.01% | 6150 |
|
|
2021
Q3 | $269K | Sell |
12,844
-3,976
| -24% | -$85.4K | ﹤0.01% | 6090 |
|
|
2021
Q2 | $402K | Buy |
16,820
+4,291
| +34% | +$109K | ﹤0.01% | 5590 |
|
|
2021
Q1 | $367K | Buy |
12,529
+7,482
| +148% | +$219K | ﹤0.01% | 5614 |
|
|
2020
Q4 | $150K | Buy |
+5,047
| New | +$158K | ﹤0.01% | 5772 |
|
Bank of America's KRON Position: Q2 2025 in Review
Bank of America sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 368 shares — an estimated $304 sold.
Bank of America first reported a position in KRON in Q4 2020 and held it in 18 quarters. The position peaked at $1.14M in Q1 2022. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.
- Bank of America reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
- Bank of America sold 368 Kronos Bio shares in Q2 2025, an estimated $304.
- Bank of America first reported a position in Kronos Bio in Q4 2020 and held it in 18 quarters.
- Bank of America's Kronos Bio position peaked at $1.14M in Q1 2022.
- 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.
Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.